Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report

登录注册会员服务联系我们

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report—Part V

Published:2010-01 Issue:1 Volume:13 Page:25-27
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Mycka Jack M.,Dellamano Renato,Kolassa Eugene Mick,Wonder Michael,Ghosh Sabyasachi,Hay Joel W.,Smeeding Jim

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is the price right? Paying for value today to get more value tomorrow;BMC Medicine;2024-01-30

2. Do Cost-Effectiveness Analyses Account for Drug Genericization? A Literature Review and Assessment of Implications;Value in Health;2022-01

3. Friction cost approach methodology in pharmacoeconomic analyses;Česká a slovenská farmacie;2021

4. The Impact of Price Reductions After Loss of Exclusivity in a Cost-Effectiveness Analysis: Fingolimod Versus Interferon Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis;Journal of Managed Care & Specialty Pharmacy;2019-04

5. Review of studies reporting actual prices for medicines;Expert Review of Pharmacoeconomics & Outcomes Research;2018-12-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP